Active Not Recruiting NA INTERVENTIONAL 1-arm NCT04730869

Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma

Feasibility, Safety, and Efficacy of a Metabolic Therapy Program in Conjunction With Standard Treatment for Glioblastoma

Sponsor: Waikato Hospital

Conditions Glioblastoma

Interventions Standard Treatment Plus Metabolic Therapy Program

Updated 9 times since 2021 Last updated: Jun 25, 2025 Started: May 26, 2021 Primary completion: Feb 18, 2025 Completion: Jun 26, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Glioblastoma, this trial is ongoing. The trial is conducted by Waikato Hospital and has accumulated 9 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Jul 2025 — Present [monthly]

Active Not Recruiting NA
Oct 2024 — Jul 2025 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Sep 2024 — Oct 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Sep 2023 — Jul 2024 [monthly]

Recruiting NA

▶ Show 4 earlier versions

May 2023 — Sep 2023 [monthly]

Recruiting NA
Sep 2021 — May 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
May 2021 — Sep 2021 [monthly]

Not Yet Recruiting NA
Feb 2021 — May 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Waikato Hospital
Wellington Hospital

Data source: Waikato Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, New Zealand